Sirolimus rescue for tacrolimus-associated post-transplant autoimmune hemolytic anemia

Pediatr Transplant. 2006 May;10(3):358-61. doi: 10.1111/j.1399-3046.2005.00460.x.

Abstract

Autoimmune hemolytic anemia (AIHA) has been reported to occur after renal transplantation, and typically does so in the first few weeks post-transplant. We report on a 3-yr-old child who developed cold AIHA nearly 1 yr after an ABO identical, living donor renal transplant from his mother. Numerous transfusions, pulse steroids, repeat plasma exchange treatments, and IVIG were unsuccessful. Nearly 3 wk into his illness, tacrolimus was changed to cyclosporine, and then to sirolimus, and resulted in a prompt response. He currently has a normal renal function and a normal hemoglobin level on sirolimus monotherapy.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Hemolytic, Autoimmune / drug therapy*
  • Anemia, Hemolytic, Autoimmune / etiology*
  • Child, Preschool
  • Humans
  • Immunoglobulins, Intravenous / pharmacology
  • Immunosuppressive Agents / pharmacology
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / methods
  • Nephrotic Syndrome / congenital
  • Nephrotic Syndrome / therapy
  • Sirolimus / pharmacology*
  • Tacrolimus / adverse effects*
  • Time Factors
  • Treatment Outcome

Substances

  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Sirolimus
  • Tacrolimus